Vitamin B6 Status Detection via Erythrocyte PLP-DE Probe

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining vitamin B6 status in subjects are limited by the instability of pyridoxal phosphate (PLP) in plasma samples, variability due to factors like inflammation and alcohol consumption, and the time-consuming processing required for functional assays.

Innovation Solution

An in vitro method involving the use of a probe with functionalized cofactors of PLP-dependent enzymes (PLP-DEs) to capture and label PLP-DEs in erythrocytes, followed by detection with anti-PLP-DE antibodies, allowing for rapid determination of vitamin B6 status.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If plasma PLP levels are measured using HPLC, then the vitamin B6 status can be determined, but the measurement precision is affected by PLP instability and binding to hemoglobin

Engineering Contradiction:
ImprovePLP measurement precisionVSAvoidPLP stability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention extracts and measures erythrocyte PLP levels separately from plasma components. By isolating the intracellular PLP measurement from plasma matrix effects and hemoglobin binding interference, the method achieves more reliable and precise vitamin B6 status assessment without the confounding factors present in plasma measurements.

Inventive Principle:
Principle #2Taking out (Extraction)

2Measurement precision

If functional B6 biomarker tests are performed on fresh blood, then the vitamin status assessment is more accurate, but the processing time increases significantly

Engineering Contradiction:
Improvevitamin status assessment accuracyVSAvoidblood processing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention performs preliminary isolation of erythrocytes from whole blood before functional analysis. By pre-separating the red blood cells containing the PLP-dependent enzymes from plasma and other components, the method enables subsequent rapid functional testing without requiring extensive fresh blood processing, thus reducing overall analysis time while maintaining accuracy.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If multiple PLP-dependent enzymes are analyzed, then personalized vitamin B6 status parameters can be obtained, but the device complexity increases

Engineering Contradiction:
Improvepersonalized parameter assessmentVSAvoidassay system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention employs a universal functional assay approach where a single test system can analyze multiple PLP-dependent enzymes simultaneously. By using a common methodology to assess various enzymes (such as transaminases, decarboxylases, and other PLP-DEs), the system provides personalized vitamin B6 status parameters across different enzyme activities without requiring separate complex diagnostic platforms for each enzyme.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a rapid, reliable, and personalized assessment of vitamin B6 status, independent of free PLP stability and fluctuations, and can be performed with minimal equipment, making it suitable for point-of-care testing.

Implementation Method 1

treating the lysate with a probe comprising at least one functionalized cofactor of PLP-dependent enzymes (PLP-DEs)

Methodology Applied
Scientific EffectCofactor-enzyme binding: Enzyme

Implementation Method 2

capturing the labeled PLP-DEs with anti-PLP-DE-antibodies immobilized on a surface

Methodology Applied
Scientific EffectAntigen-antibody binding:

Data Source

PatentUS20250102527A1Method and device for determining the vitamin status
Publication Date: 2025.03.27 TECHNISCHE UNIVERSITAT MUNCHEN
  • US20250102527A1 patent drawing
  • US20250102527A1 patent drawing
  • US20250102527A1 patent drawing

AI summary

The present invention relates to in vitro methods for determining the vitamin status of a subject, in particular health related vitamins, such as B2, B6, B12 and/or D3. The present invention further relates to a kit and an immunographic device for in vitro determining the vitamin status of a subject.